TrialsgrambetaRCTs are beautiful

CoBalT

2013

CBT as Adjunct in Treatment-Resistant Depression

In 469 primary-care patients with antidepressant-resistant depression, 12–18 sessions of CBT added to usual care improved 6-month response and sustained benefit at 46 months compared with usual care alone.

Result

Efficacy: ≥50% BDI reduction at 6 monthsOR 3.26

Below 1 favours usual care alone, above 1 favours 12–18 sessions of CBT added to usual care.

Event rates
Absolute difference
24 points

The absolute difference is derived from the event rates.

Also reported: Benefit persisted at 46 months (Lancet Psychiatry 2016).

Original publication
Subtopic
Treatment-resistant
Design
Multicentre RCT, UK
Relevance
Important: one of several pillars.
Source
Wiles N, et al. Lancet. 2013;381(9864):375-384.doi 10.1016/S0140-6736(12)61552-9

Discussion & critique

Established CBT as a routine second-line strategy in primary care before further drug switches.